Updates | Events | HIGHLIGHTS
Vesalius in the News
Vesalius is recognized on the 2020 Life Science Emerging Rocket List as a Top Technology Company
April 14, 2020 - Ready to Rocket, British Columbia (BC) Rocket Builders today released its eighteenth (18th) annual “Ready to Rocket” lists. These lists profile British Columbia technology companies that are best positioned to capitalize on the technology sector...
Vesalius Cardiovascular Announces the Completion of a Successful Chronic Animal Study
VANCOUVER, British Columbia, January 21, 2020 (Newswire.com) Vesalius Cardiovascular Inc. (VCI), a pre-clinical stage medical device company developing novel percutaneous therapies for the treatment of mitral regurgitation, today announced the successful completion of...
Vesalius is selected to pitch at the 2019 Life Sciences British Columbia (LSBC) Investors Summit
November 6, 2019 - JW Marriott Parq Hotel, Vancouver For the third year in a row, Vesalius is selected to pitch at the LSBC Investors Summit, a regional event held to connect investor stakeholders with the healthcare innovation industry through company pitches,...
Vesalius team is attending TCT 2019 in San Francisco
September 25-29, 2019 - Moscone Convention Center, San Francisco Vesalius team is attending TCT 2019 in San Francisco. This very specialized conference is the ideal occasion to learn more about the latest therapies in interventional cardiology and connect with...
Vesalius wins top prize of $300,000 at the 2019 VGH and UBC Hospital Foundation Innovators’ Challenge
May 9, 2019 - VGH and UBC Hospital Foundation Innovators’ Challenge, Vancouver The VGH and UBC Hospital Foundation Innovators’ Challenge looks for three local medical teams involved in groundbreaking research and development to pitch their innovations to the...
Vesalius is recognized on the 2019 Ready to Rocket Life Science List
March 12, 2019 - Ready to Rocket, British Columbia (BC) Ready to Rocket is a recognition program for BC’s tech sector, publishing the revenue growth leaders of tomorrow. Based on their analysis of Vesalius, they determined the company is one of “the top private...
Vesalius is featured in the Life Sciences Bristish Columbia (LSBC) Annual Magazine 2019
February 20, 2019 - LSBC, Vancouver As the premier marketing piece for the BC life science ecosystem, LifeSciences BC publishes an annual magazine that identifies the innovation, pace and significant accomplishments of the life sciences sector in the last year. The...
Vesalius is selected to pitch at the 2018 Life Sciences British Columbia (LSBC) Investors Summit
October 25, 2018 - Fairmont Pacific Rim, Vancouver The LSBC Investors Summit is held to connect investor stakeholders with the healthcare innovation industry through company pitches and discussions. They chose Vesalius to pitch at the Investors Summit, giving Vesalius...
Vesalius Cardiovascular Closes $1M Seed Investment Round – Plans Series-A Financing by End of Year
Vancouver, BC, May 28, 2018--(entrepreneurship@UBC)--Vesalius Cardiovascular Inc. has announced the closing of a $1 million seed financing round to accelerate the engineering of its mitral valve repair device called Calla TC3. The Vesalius unique concept marries...
Vesalius has been preselected to pitch at the 2018 UBC Investors Day in Vancouver
May 8, 2018 - University of British Columbia (UBC) Robson Square, Vancouver After HATCH’s prescreening for innovative companies, Vesalius is pitching at UBC Investors Day. This opportunity allows Vesalius to increase awareness about their research project and make...